Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection in Women

NCT02568215 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1924

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: VRC01
BIOLOGICAL: Placebo for VRC01

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)